Your browser doesn't support javascript.
loading
Understanding the potential of lactobacilli in recurrent UTI prevention.
Vagios, Stylianos; Hesham, Helai; Mitchell, Caroline.
  • Vagios S; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Vincent Center for Reproductive Biology, Massachusetts General Hospital Research Institute, USA.
  • Hesham H; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Vincent Center for Reproductive Biology, Massachusetts General Hospital Research Institute, USA.
  • Mitchell C; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Vincent Center for Reproductive Biology, Massachusetts General Hospital Research Institute, USA. Electronic address: Caroline.mitchell@mgh.harvard.edu.
Microb Pathog ; 148: 104544, 2020 Nov.
Article en En | MEDLINE | ID: mdl-33010368
Urinary tract infections (UTIs) are one of the most common infections in women. The only proven preventive strategy for recurrent UTIs is prophylactic antibiotics. Given growing antibiotic resistance, the use of probiotics has been proposed as an alternative to antibiotics. Herein, we discuss the current evidence to support the possibility that exogenous lactobacilli may limit the pathogenicity of uropathogens such as E. coli. Probiotics appear to have a significant potential in prevention of recurrent UTI, however, additional data are needed to understand how they can be effectively used in clinical practice.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Urinarias / Probióticos / Infecciones por Escherichia coli Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Urinarias / Probióticos / Infecciones por Escherichia coli Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article